Poseida Therapeutics, Inc.
PSTX
Revenue
71.75M
▲45.78M▲176.24%
3 Months ChangeAssets
293.58M
▼-5.11M▼-1.71%
3 Months ChangeLiabilities
206.37M
▼-31.50M▼-13.24%
3 Months ChangeFree Cash Flow
-15.27M
▲23.52M▲60.65%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-30
Form 8-K
ID: 0001193125-24-228441
2024-08-05
Form 10-Q
ID: 0000950170-24-090747
2024-08-05
Form 8-K
ID: 0000950170-24-090732
2024-06-18
Form 8-K
ID: 0000950170-24-074860
2024-05-14
Form 10-Q
ID: 0000950170-24-059551
2024-05-14
Form 8-K
ID: 0000950170-24-059522
2024-05-01
Form 8-K
ID: 0001193125-24-126509
2024-04-17
Form 8-K
ID: 0001193125-24-098680
2024-04-08
Form 8-K
ID: 0001193125-24-089653
2024-03-07
Form 8-K
ID: 0000950170-24-027932